CANCER ALLIANCE PUBLISHES SECTION 4 OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: TREATMENT & PALLIATIVE CARE

with No Comments

Breast Cancer Control Policy 2017 25th February 2019 The Cancer Alliance today publishes the fourth and final part of its series on the Breast Cancer Control Policy with Section 4: Treatment & Palliative Care South Africa’s new Breast Cancer Control … Read More

OPEN LETTER TO THE SOUTH AFRICAN HEALTH PRODUCTS REGULATORY AUTHORITY (SAHPRA) ON ACCESS TO AFFORDABLE TRASTUZUMAB TREATMENT FOR WOMEN DIAGNOSED WITH HER2+

with No Comments

11 December 2018 Prof Helen Rees Chairperson: SAHPRA Dear Professor Rees and officials at SAHPRA, This letter could have been composed by ANY of the women in South Africa, diagnosed with HER2+ Breast Cancer who have been denied access to … Read More

CANCER ALLIANCE PUBLISHES SECTION 2 OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: AWARENESS AND PREVENTION

with No Comments

Breast Cancer Control Policy 2017 26th November 2018 The Cancer Alliance today continues its series on the Breast Cancer Control Policy with Section 2: Awareness and Prevention. South Africa’s new Breast Cancer Control Policy is a vital document aimed at … Read More

CANCER ALLIANCE PUBLISHES THE FIRST SECTION OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: THE NEW POLICY

with No Comments

Breast Cancer Prevention and Control Policy 2017 The Cancer Alliance today publishes the first in a new series on the Breast Cancer Prevention and Control Policy 2017. South Africa’s new Breast Cancer Prevention and Control Policy is a vital document … Read More

1 2 3
Subscribe to our email list

Subscribe to our mailing list for regular updates on publications and events. Your contact details will only be used to send you details of the activities of the Cancer Alliance, and will be kept strictly confidential at all times.

You may unsubscribe from this list at any time.

Please note: This subscription requires you to confirm your entry before you are added to our database. After you press Subscribe Now you will receive an email at the address you provided and must reply before you are added to our database.